Company intelligence / Profile preview

Priveq Investment

Stockholm, Sweden

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Priveq Investment is a Stockholm-based private equity firm founded in 1983, focusing on growth-stage companies in the Nordics, particularly Sweden, across sectors including manufacturing, software, and health care. It has made over 140 investments, with 29 IPOs from its portfolio companies. While not a life science/biotech/pharma company itself, it has invested in health-related companies, including 4 in Health Care and 3 in Medical Device, with notable exits such as Metenova (MedTech for pharmaceutical mixers, sold to Repligen in 2023).

Industry: Investors

Beyond the preview

Go deeper on Priveq Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Priveq Investment.

Explore the full profile